The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Important Update on FDA Changes Concerning Peptides Did you know some preclinical studies report Dihexa showing neurotrophic activity far exceeding BDNF in laboratory assays? Research links its mechanism to HGF c Met signaling and synaptic plasticity in animal models. Human data Can Dihexa Really Boost Energy and Metabolism? Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like